These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17619235)

  • 21. The social benefits of restoring water quality in the context of the Water Framework Directive: A comparison of willingness to pay and willingness to accept.
    Del Saz-Salazar S; Hernández-Sancho F; Sala-Garrido R
    Sci Total Environ; 2009 Aug; 407(16):4574-83. PubMed ID: 19473689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical implications of response acquiescence in discrete-choice contingent valuation.
    Yeung RY; Smith RD; Ho LM; Johnston JM; Leung GM
    Health Econ; 2006 Oct; 15(10):1077-89. PubMed ID: 16518835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits transfer of willingness to pay estimates and functions for health-risk reductions: a cross-country study.
    Brouwer R; Bateman IJ
    J Health Econ; 2005 May; 24(3):591-611. PubMed ID: 15811545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring.
    Schwarzinger M; Carrat F; Luchini S
    J Health Econ; 2009 Jul; 28(4):873-84. PubMed ID: 19362383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of risk representation and scope on willingness to pay for reduced risks: evidence from Tokyo Bay, Japan.
    Zhai G; Suzuki T
    Risk Anal; 2008 Apr; 28(2):513-22. PubMed ID: 18419666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bias against new innovations in health care: value uncertainty and willingness to pay.
    Walton SM; Graves PE; Mueser PR; Dow JK
    Value Health; 2002; 5(2):67-70. PubMed ID: 11918821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warm glow, free-riding and vehicle neutrality in a health-related contingent valuation study.
    Hackl F; Pruckner GJ
    Health Econ; 2005 Mar; 14(3):293-306. PubMed ID: 15386649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Air quality improvement estimation and assessment using contingent valuation method, a case study in Beijing.
    Wang XJ; Zhang W; Li Y; Yang KZ; Bai M
    Environ Monit Assess; 2006 Sep; 120(1-3):153-68. PubMed ID: 16770506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to pay for reductions in angina pectoris attacks.
    Kartman B; Andersson F; Johannesson M
    Med Decis Making; 1996; 16(3):248-53. PubMed ID: 8818123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.
    O'Brien B; Gafni A
    Med Decis Making; 1996; 16(3):288-99. PubMed ID: 8818128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The demand for health insurance coverage for tobacco dependence treatments: support for a benefit mandate and willingness to pay.
    Halpin HA; McMenamin SB; Shade SB
    Nicotine Tob Res; 2007 Dec; 9(12):1269-76. PubMed ID: 18058345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
    Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'.
    Yeung RY; Smith RD; McGhee SM
    Health Econ; 2003 Sep; 12(9):791-6. PubMed ID: 12950096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh.
    Heinzen RR; Bridges JF
    Int J Technol Assess Health Care; 2008; 24(4):481-7. PubMed ID: 18828944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does willingness to pay per quality-adjusted life year bring us closer to a useful decision rule for cost-effectiveness analysis?
    Polsky D
    Med Decis Making; 2005; 25(6):605-6. PubMed ID: 16282209
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of risk information on patients' willingness to pay for autologous blood donation.
    Lee SJ; Liljas B; Neumann PJ; Weinstein MC; Johannesson M
    Med Care; 1998 Aug; 36(8):1162-73. PubMed ID: 9708589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities and the willingness to pay for reducing the risk of a targeted disease: introducing endogenous effort for risk reduction.
    Liu L
    Health Econ; 2004 May; 13(5):493-8. PubMed ID: 15127428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Willingness to pay for telemedicine assessed by the double-bounded dichotomous choice method.
    Bradford WD; Kleit AN; Krousel-Wood MA; Re RM
    J Telemed Telecare; 2004; 10(6):325-30. PubMed ID: 15603629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gain.
    Smith RD
    Health Econ; 2006 Mar; 15(3):281-93. PubMed ID: 16200558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influences of the absence of random assignment of bids on estimating willingness to pay using a discrete-choice question.
    Takemura S; Ohida T; Sone T; Fukuda T; Takemura Y
    Health Econ; 2005 Feb; 14(2):209-13. PubMed ID: 15386653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.